Nano-X Imaging (NNOX) EBIT Margin (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly EBIT Margin of 337.69% for Q1 2026, up 16284.0% year-on-year from N/an in Q1 2025, and up 64.54% on a QoQ basis from 952.35% in Q4 2025.
Nano-X Imaging (NNOX) EBIT Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported EBIT Margin for 5 consecutive years, with 337.69% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin rose 16284.0% year-over-year to 337.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 542.14% (down 4226.0% YoY) and the FY2025 annual result came in at 600.83%, down 9790.0% from the prior year.
- EBIT Margin climbed to 337.69% in Q1 2026 per NNOX's latest filing, from 952.35% in the prior quarter.
- Over the last five years, EBIT Margin for NNOX reached as high as 337.69% in Q1 2026 and fell as low as 2521.39% in Q4 2022.
- A 5-year average of 751.25% and a median of 514.1% in 2024 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2023 — EBIT Margin jumped 207554 bps — and 2025, when it sank 45319 bps.
- Year by year, EBIT Margin stood at 2521.39% in 2022, then surged by 82 bps to 445.85% in 2023, then fell by 12 bps to 499.17% in 2024, then slumped by 91 bps to 952.35% in 2025, then jumped by 65 bps to 337.69% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 337.69%, 952.35%, and 412.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -337.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -337.69% |
| Dec 31, 2025 | -952.35% |
| Sep 30, 2025 | -412.97% |
| Jun 30, 2025 | -476.68% |
| Mar 31, 2025 | -500.53% |
| Dec 31, 2024 | -499.17% |
| Sep 30, 2024 | -466.48% |
| Jun 30, 2024 | -537.50% |
| Mar 31, 2024 | -514.10% |
| Dec 31, 2023 | -445.85% |
| Sep 30, 2023 | -887.17% |
| Jun 30, 2023 | -690.59% |
| Mar 31, 2023 | -493.58% |
| Dec 31, 2022 | -2,521.39% |
| Sep 30, 2022 | -813.33% |
| Jun 30, 2022 | -1,008.32% |
| Mar 31, 2022 | -1,213.61% |